North America hemodynamic monitoring systems market is projected to grow by 6.3% annually in the forecast period and reach $ 826.1 million by 2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic.
Highlighted with 21 tables and 38 figures, this 97-page report “North America Hemodynamic Monitoring Systems Market 2021-2031 by Component (Catheters, Sensors, Monitoring Devices, Probes, Others), Modality (Invasive, Minimally Invasive, Non-Invasive), Setting (Hospitals, Clinics, Ambulatory Care Units, Homecare, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America hemodynamic monitoring systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America Hemodynamic monitoring systems market in every aspect of the classification from perspectives of Component, Modality, Setting, and Country.
Based on Component, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Catheters
• Sensors
• Monitoring Devices
• Probes
• Other Components
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Manmayi Raval
Research Consultant
Based on Modality, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Invasive Monitoring
• Minimally Invasive Monitoring
• Non-Invasive Monitoring
By Setting, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Clinics
• Ambulatory Care Units
• Homecare
• Other Settings
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Modality, and Setting over the forecast years are also included.
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Baxter International Inc.
Caretaker, LLC
Cheetah Medical Inc.
CN Systems Medizintechnik GmbH
Deltex Medical Group PLC
Dragerwerk AG & Co. KGaA
Edwards Lifesciences Corporation
Flosonics Medical
GE Healthcare
Getinge Group
Heart Kinetics
ICU Medical Inc.
Koninklijke Philips N.V.
Lidco Group PLC
Masimo Corporation
NI Medical Ltd.
Osypka Medical GmbH
Retia Medical
Schwarzer Cardiotek
Sramek BioDynamics Inc.
Uscom Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porter’s Fiver Forces Analysis 38
3 Segmentation of North America Market by Component 42
3.1 Market Overview by Component 42
3.2 Catheters 44
3.3 Sensors 45
3.4 Monitoring Devices 46
3.5 Probes 47
3.6 Other Components 48
4 Segmentation of North America Market by Modality 49
4.1 Market Overview by Modality 49
4.2 Invasive Monitoring 51
4.3 Minimally Invasive Monitoring 52
4.4 Non-Invasive Monitoring 53
5 Segmentation of North America Market by Setting 54
5.1 Market Overview by Setting 54
5.2 Hospitals 56
5.3 Clinics 57
5.4 Ambulatory Care Units 58
5.5 Homecare 59
5.6 Other Settings 60
6 North America Market 2021-2031 by Country 61
6.1 Overview of North America Market 61
6.2 U.S. 64
6.3 Canada 67
6.4 Mexico 69
7 Competitive Landscape 71
7.1 Overview of Key Vendors 71
7.2 New Product Launch, Partnership, Investment, and M&A 74
7.3 Company Profiles 75
Baxter International Inc. 75
Caretaker, LLC 77
Cheetah Medical Inc. 78
CN Systems Medizintechnik GmbH 79
Deltex Medical Group PLC 80
Dragerwerk AG & Co. KGaA 81
Edwards Lifesciences Corporation 82
Flosonics Medical 83
GE Healthcare 84
Getinge Group 85
Heart Kinetics 86
ICU Medical Inc. 87
Koninklijke Philips N.V. 88
Lidco Group PLC 89
Masimo Corporation 90
NI Medical Ltd. 91
Osypka Medical GmbH 92
Retia Medical 93
Schwarzer Cardiotek 94
Sramek BioDynamics Inc. 95
Uscom Ltd. 96
RELATED REPORTS 97
List of Figures:
Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 15
Figure 4. Industry Value Chain Analysis 17
Figure 5. North America Hemodynamic Monitoring Systems Market, 2021-2031, $ mn 18
Figure 6. Impact of COVID-19 on Business 21
Figure 7. Primary Drivers and Impact Factors of North America Hemodynamic Monitoring Systems Market 23
Figure 8. Worldwide Prevalence of Cardiovascular Disorders, 1990-2019, million 26
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 29
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 29
Figure 11. Primary Restraints and Impact Factors of North America Hemodynamic Monitoring Systems Market 31
Figure 12. Investment Opportunity Analysis 35
Figure 13. Porter’s Fiver Forces Analysis of North America Hemodynamic Monitoring Systems Market 38
Figure 14. Breakdown of North America Hemodynamic Monitoring Systems Market by Component, 2021-2031, % of Revenue 43
Figure 15. North America Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 43
Figure 16. North America Hemodynamic Monitoring Systems Market by Component: Catheters, 2021-2031, $ mn 44
Figure 17. North America Hemodynamic Monitoring Systems Market by Component: Sensors, 2021-2031, $ mn 45
Figure 18. North America Hemodynamic Monitoring Systems Market by Component: Monitoring Devices, 2021-2031, $ mn 46
Figure 19. North America Hemodynamic Monitoring Systems Market by Component: Probes, 2021-2031, $ mn 47
Figure 20. North America Hemodynamic Monitoring Systems Market by Component: Other Components, 2021-2031, $ mn 48
Figure 21. Breakdown of North America Hemodynamic Monitoring Systems Market by Modality, 2021-2031, % of Sales Revenue 50
Figure 22. North America Addressable Market Cap in 2022-2031 by Modality, Value ($ mn) and Share (%) 50
Figure 23. North America Hemodynamic Monitoring Systems Market by Modality: Invasive Monitoring, 2021-2031, $ mn 51
Figure 24. North America Hemodynamic Monitoring Systems Market by Modality: Minimally Invasive Monitoring, 2021-2031, $ mn 52
Figure 25. North America Hemodynamic Monitoring Systems Market by Modality: Non-Invasive Monitoring, 2021-2031, $ mn 53
Figure 26. Breakdown of North America Hemodynamic Monitoring Systems Market by Setting, 2021-2031, % of Sales Revenue 55
Figure 27. North America Addressable Market Cap in 2022-2031 by Setting, Value ($ mn) and Share (%) 55
Figure 28. North America Hemodynamic Monitoring Systems Market by Setting: Hospitals, 2021-2031, $ mn 56
Figure 29. North America Hemodynamic Monitoring Systems Market by Setting: Clinics, 2021-2031, $ mn 57
Figure 30. North America Hemodynamic Monitoring Systems Market by Setting: Ambulatory Care Units, 2021-2031, $ mn 58
Figure 31. North America Hemodynamic Monitoring Systems Market by Setting: Homecare, 2021-2031, $ mn 59
Figure 32. North America Hemodynamic Monitoring Systems Market by Setting: Other Settings, 2021-2031, $ mn 60
Figure 33. Breakdown of North America Hemodynamic Monitoring Systems Market by Country, 2021 and 2031, % of Revenue 62
Figure 34. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 63
Figure 35. U.S. Hemodynamic Monitoring Systems Market, 2021-2031, $ mn 65
Figure 36. Canada Hemodynamic Monitoring Systems Market, 2021-2031, $ mn 67
Figure 37. Hemodynamic Monitoring Systems Market in Mexico, 2021-2031, $ mn 69
Figure 38. Growth Stage of North America Hemodynamic Monitoring Systems Industry over the Forecast Period 71
List of Tables:
Table 1. Snapshot of North America Hemodynamic Monitoring Systems Market in Balanced Perspective, 2021-2031 16
Table 2. World Economic Outlook, 2021-2031 20
Table 3. Worldwide Diabetes Prevalence, 2000 — 2045 26
Table 4. World Health Spending by Region, $ bn, 2013-2020 30
Table 5. Main Product Trends and Market Opportunities in North America Hemodynamic Monitoring Systems Market 34
Table 6. North America Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 42
Table 7. North America Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 49
Table 8. North America Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 54
Table 9. North America Hemodynamic Monitoring Systems Market by Country, 2021-2031, $ mn 62
Table 10. U.S. Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 66
Table 11. U.S. Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 66
Table 12. U.S. Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 66
Table 13. Canada Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 68
Table 14. Canada Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 68
Table 15. Canada Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 68
Table 16. Mexico Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 70
Table 17. Mexico Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 70
Table 18. Mexico Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 70
Table 19. Baxter International Inc.: Company Snapshot 75
Table 20. Baxter International Inc.: Business Segmentation 76
Table 21. Baxter International Inc.: Product Portfolio 76
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More